- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD) in United States
Total 675 results
-
National Institute of Diabetes and Digestive and...CompletedFatty LiverUnited States
-
Emory UniversityResonance HealthCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
San Antonio Military Medical CenterCompletedFatty LiverUnited States
-
Massachusetts General HospitalActive, not recruitingObesity | Fatty Liver | Liver Fat | Obesity, Abdominal | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Pinnacle Clinical Research, PLLCCompletedFatty Liver | Fibrosis, Liver | Compensated Cirrhosis | Non-alcoholic SteatohepatitisUnited States
-
Brooke Army Medical CenterCompleted
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
CohBar, Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States
-
AstraZenecaParexelCompletedNon-alcoholic Steatohepatitis (NASH)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNonalcoholic Fatty Liver Disease | PhysicianUnited States
-
Massachusetts General HospitalCompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University of California, San DiegoEmory University; Nutrition Science InitiativeCompleted
-
Imperial College LondonEnrolling by invitationCardiovascular Diseases | Diabetes | Respiratory Disease | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
US Department of Veterans AffairsCompleted
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Novartis PharmaceuticalsCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
Intercept PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, Finland, France, Spain, United Kingdom, Israel, Austria, Italy, Denmark, Germany, Belgium, Switzerland, Puerto Rico, Poland, Australia, Sweden, Serbia, New Zealand, Canada, Hungary, Portugal
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Corcept TherapeuticsCompletedNon-alcoholic Steatohepatitis (NASH) | Antipsychotic Induced Weight GainUnited States
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited Kingdom, Spain, United States, France, Germany
-
Conatus Pharmaceuticals Inc.TerminatedLiver Diseases | Liver Cirrhosis | Liver Fibrosis | NASH Fibrosis | Decompensated Non-Alcoholic Steatohepatitis Cirrhosis | Orthotopic Liver TransplantationUnited States
-
Wake Forest University Health SciencesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Active, not recruitingDiabetes | Nonalcoholic Fatty Liver | IronUnited States
-
University of LiverpoolRecruitingHeart Failure | Obstructive Sleep Apnea | Type 2 Diabetes | Pre Diabetes | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico
-
Massachusetts General HospitalUniversity of California, San Diego; Foundation for the National Institutes...CompletedNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
Marc GoodmanCompletedLiver Diseases | Fatty Liver, NonalcoholicUnited States
-
Arisaph Pharmaceuticals IncUnknownNonalcoholic SteatohepatitisUnited States
-
Sagimet Biosciences Inc.CompletedCirrhosis | Hepatic Impairment | Non-alcoholic SteatohepatitisUnited States, Hungary
-
Indiana UniversityCompletedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Poxel SACompletedNonalcoholic Fatty LiverUnited States
-
Tasly Biopharmaceuticals Co., Ltd.RecruitingNonalcoholic SteatohepatitisUnited States
-
Erchonia CorporationWithdrawnNonalcoholic SteatohepatitisUnited States
-
Case Western Reserve UniversityAmerican College of GastroenterologyCompletedNonalcoholic SteatohepatitisUnited States
-
Keith D Lindor, M.D.Ajinomoto USA, INC.CompletedNonalcoholic SteatohepatitisUnited States
-
AmgenCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Northwestern UniversityCompletedLiver Diseases | Nonalcoholic SteatohepatitisUnited States
-
Altimmune, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Duke UniversityTerminatedFatty LiverUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
Altimmune, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more